Amundi
DVAX

Amundi’s Dynavax Technologies DVAX Stock Holding History

Amundi’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,854
Closed -$290K – 2055
2025
Q4 		$290K Sell
18,854
-420
-2% -$4.63K ﹤0.01% 1659
2025
Q3 		$195K Buy
19,274
+233
+1% +$2.42K ﹤0.01% 1544
2025
Q2 		$193K Sell
19,041
-30,472
-62% -$321K ﹤0.01% 1615
2025
Q1 		$636K Sell
49,513
-9,383
-16% -$124K ﹤0.01% 1443
2024
Q4 		$743K Buy
58,896
+37,290
+173% +$451K ﹤0.01% 1479
2024
Q3 		$230K Buy
21,606
+1,773
+9% +$19.5K ﹤0.01% 1625
2024
Q2 		$219K Sell
19,833
-3,109
-14% -$36.2K ﹤0.01% 1563
2024
Q1 		$260K Buy
22,942
+5,905
+35% +$77K ﹤0.01% 1583
2023
Q4 		$237K Buy
17,037
+753
+5% +$10.5K ﹤0.01% 1591
2023
Q3 		$232K Buy
16,284
+1,198
+8% +$16.8K ﹤0.01% 1558
2023
Q2 		$193K Buy
+15,086
New +$172K ﹤0.01% 1612

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amundi's DVAX Position: Q1 2026 in Review

Amundi sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 18,854 shares — an estimated $290K sold.

Amundi first reported a position in DVAX in Q2 2023 and held it in 11 quarters. The position peaked at $743K in Q4 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Amundi reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Amundi sold 18,854 Dynavax Technologies shares in Q1 2026, an estimated $290K.
  • Amundi first reported a position in Dynavax Technologies in Q2 2023 and held it in 11 quarters.
  • Amundi's Dynavax Technologies position peaked at $743K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.